CVRx shares rise on CMS inclusion for Barostim implant procedure
Source: SeekingAlpha
2025-07-16 16:08:29 ET
More on CVRx
- CVRx: Sell-Off Ignores Its True Potential
- CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript
- CVRx downgraded at J.P. Morgan after Q1 sales miss
- Seeking Alpha’s Quant Rating on CVRx
- Historical earnings data for CVRx
Read the full article on Seeking Alpha
For further details see:
CVRx shares rise on CMS inclusion for Barostim implant procedure
CVRx Inc.
NASDAQ: CVRX
CVRX Trading
1.13% G/L:
$7.58 Last:
74,533 Volume:
$7.39 Open:
CVRX Latest News
March 02, 2026 08:30:00 am
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
February 12, 2026 04:05:00 pm
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
CVRX Stock Data
$174,952,478
20,522,515
15.36%
28
N/A
Medical Equipment & Supplies
Healthcare
US
Minneapolis
